RE:Is Brexit really a done deal?I only have been on this board since CXR was $5 CAD or less. I think it's very important anyone understands what happened to the company over it's lifespan under it's founder and former CEO Mark Thompson
That being said, I do believe that Concordia is going to try to become a new company and having the old CEO and his sentimental feelings towards the company gone will provide the foundation of a turn around story.
Over the last two quarters, CXR has been under consistently and increasing short selling by some large large players. This is because of the controversial drug pricing, or what some would call "gouging" of a few of CXR's drugs. Personally, what this means for the bottom line and the company going forward is entirely speculation. No one knows what the governments and CXR's mgmt team will agree too.
That being said, CXR has been shorted to oblivion and beyond. That is why it is so compelling now. I feel bad for those shareholders who lost everything but really it's an opportunity to me